Bayer Net Change in Property, Plant, and Equipment 2010-2024 | BAYRY
Bayer annual/quarterly net change in property, plant, and equipment history and growth rate from 2010 to 2024. Net change in property, plant, and equipment can be defined as the overall change in capital expenditures and sales of plant, property and equipment. This field is used if a company does not report separately sales and purchases of plant, property and equipment or is calculated as the sum of purchases and sales of PP&E
- Bayer net change in property, plant, and equipment for the quarter ending December 31, 2024 was $-2.687B, a 2.11% decline year-over-year.
- Bayer net change in property, plant, and equipment for the twelve months ending December 31, 2024 was $-5.805B, a 3.99% decline year-over-year.
- Bayer annual net change in property, plant, and equipment for 2024 was $-2.687B, a 2.11% decline from 2023.
- Bayer annual net change in property, plant, and equipment for 2023 was $-2.745B, a 43.22% increase from 2022.
- Bayer annual net change in property, plant, and equipment for 2022 was $-1.916B, a 27.62% decline from 2021.
Bayer Annual Net Change in Property, Plant, and Equipment
(Millions of US $) |
| 2024 |
$-2,687 |
| 2023 |
$-2,745 |
| 2022 |
$-1,916 |
| 2021 |
$-2,648 |
| 2020 |
$-2,386 |
| 2019 |
$-2,651 |
| 2018 |
$-2,791 |
| 2017 |
$-2,402 |
| 2016 |
$-2,730 |
| 2015 |
$-2,581 |
| 2014 |
$-2,962 |
| 2013 |
$-2,662 |
| 2012 |
$-2,189 |
| 2011 |
$-1,866 |
| 2010 |
$-1,929 |
| 2009 |
$-2,060 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$26.329B |
$50.438B |
|
Bayer AG is a life science company with core competencies in the areas of health care and agriculture. With the company's focus completely on the Life Science businesses, a new organizational structure was introduced effective Jan 1, 2016. Bayer Group now comprise exclusively of the Life Science businesses. The company started reporting in three segments ' Pharmaceuticals, Consumer Health and Crop Science ' from the third quarter of 2019. Both Animal Health and Currenta were reported as discontinued operations in the quarter. The company acquired U.S. seed giant Monsanto in June, 2018. With the acquisition, Bayer now has the strongest portfolio of seed and crop protection products for a wide range of crops and indications, the best research and development platform and the leading digital farming business.
|
